Literature DB >> 31242512

Preventive Effects of Probiotic Supplementation on Neonatal Hyperbilirubinemia Caused by Isoimmunization.

Mehmet Mutlu1, Yakup Aslan1, Şebnem Kader1, Filiz Aktürk Acar1.   

Abstract

OBJECTIVE: Probiotic supplementation can help to improve recovery from jaundice by reducing enterohepatic circulation through the regulation of intestinal microbial flora. The aim of our study was to investigate the effect of probiotic supplementation on neonatal hyperbilirubinemia caused by isoimmunization alone. STUDY
DESIGN: Sixty neonates were randomly divided into a placebo group and a probiotic group (Lactobacillus rhamnosus GG). Serum total bilirubin (STB) levels were measured at birth and at 4, 8, 16, 24, and 36 hours of treatment (and at 48, 60, and 72 hours if necessary). Duration of phototherapy, rephototherapy requirements, and daily meconium evacuation were recorded.
RESULTS: STB and rebound STB levels at 36 hours were lower in the probiotic group than in the placebo group (p = 0.01 and p = 0.006, respectively). Meconium evacuation was more frequent in the probiotic group than in the placebo group on the second and third days of life (p = 0.002 and 0.009, respectively).
CONCLUSION: Probiotics do not affect STB levels in the first 24 hours of life or duration of phototherapy in neonates with jaundice caused by blood group incompatibility. The effect of probiotic supplementation by reducing enterohepatic circulation occurs at 36 hours of life in newborns with isoimmunization. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31242512     DOI: 10.1055/s-0039-1692690

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.

Authors:  Jennifer Joan Ryan; Noelle M Patno
Journal:  Integr Med (Encinitas)       Date:  2021-02

2.  Maternal and infant probiotic administration for morbidity of very low birth weight infants: a three-arm randomized placebo-controlled trial.

Authors:  Mahtab Matin; Aziz Homayouni-Rad; Manizheh Mostafa-Gharehbaghi; Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh-Charandabi
Journal:  Eur J Nutr       Date:  2022-05-31       Impact factor: 4.865

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.